Pharmatest is a leading brand that specializes in providing proof-of-efficacy for cancer drug candidates and testing services for skeletal diseases. With their state-of-the-art facilities and fully equipped research laboratories, Pharmatest offers a wide range of products and services to support pharmaceutical and biotechnology companies in their research and development efforts. Their comprehensive portfolio includes clinically predictive cell culture assays, organotypic 3D models, orthotopic animal models, and disseminated cancer models for cancer research.

Additionally, they offer bone cell culture assays and animal models of osteoporosis and osteoarthritis, which can also be utilized for bone safety testing. Pharmatest has a strong track record of serving a diverse range of customers worldwide, including nutraceutical companies, and has assisted in the development of new therapeutics against cancer and skeletal diseases. With their expertise and commitment to quality assurance, Pharmatest is a trusted partner for those looking to make advancements in the field of oncology and skeletal research